Ares Commercial Real Estate Corporation

ACRE Q3 2025

Reported: 2025-11-08

Ares Commercial Real Estate Corporation experienced strong performance in Q3 2025, marked by reduced office loans and improved portfolio quality, contributing to sequential earnings growth.

Key takeaways

Sequential earnings growth driven by effective management of risk-rated loans and strengthening balance sheet.
Office loan portfolio decreased by 6% quarter-over-quarter and 26% year-over-year, with 5 of 7 remaining loans rated 3 or better.
Significant progress on risk-rated 4 and 5 loans, including strategic restructuring leading to reduced CECL reserves by approximately $7 million.
Closed $93 million in new loan commitments during Q3, with continued momentum resulting in over $270 million closed in Q4 across various property types.
Ares operates one of the largest vertically integrated real estate platforms globally, enhancing sourcing and credit capabilities for future growth.

View recap

American Healthcare REIT, Inc.

AHR Q3 2025

Reported: 2025-11-08

American Healthcare REIT delivered robust Q3 2025 results, achieving a notable 16.4% increase in same-store NOI, highlighting sustained operational strength and effective asset management.

Key takeaways

Consistent growth demonstrated by seventh consecutive quarter of double-digit same-store NOI growth.
Strong external growth with over $575 million in acquisitions year-to-date, enhancing geographic diversification and operational alignment.
Projected 20% growth in normalized FFO per fully diluted share for 2025, while improving balance sheet metrics with net debt to EBITDA at 3.5x.
Published inaugural corporate responsibility report, reinforcing commitment to governance, social issues, and sustainability within operations.
Positive occupancy trends anticipated to mitigate seasonal slowdowns, driven by increasing demand from the baby boomer population.

View recap

ALX Oncology Holdings Inc.

ALXO Q3 2025

Reported: 2025-11-08

In Q3 2025, the company achieved significant progress in its clinical programs with robust data highlighting the role of CD47 as a predictive biomarker for evorpacept, positioning it favorably in the oncology landscape.

Key takeaways

Presenting compelling Phase II data at SITC underscoring CD47 expression as a key biomarker for enhanced response in HER2-positive gastric cancer patients treated with evorpacept.
Strong clinical outcomes: ORR of 65% and median PFS of over 18 months for patients with high CD47 expression, well outperforming the control group.
Cash reserves of $67 million expected to sustain operations through Q1 2027, supporting ongoing clinical development milestones.
Initial patient dosing in the Phase I trial of ALX2004 completed, with expected safety data in H1 2026.
Focused strategy to drive value-enhancing data from both evorpacept and ALX2004 is on track, with key milestones anticipated in 2026.

View recap

A.P. Moller - Maersk A/S

AMKBY Q3 2025

Reported: 2025-11-08

A.P. Møller - Maersk demonstrated solid financial performance in Q3 2025, with EBITDA rising to $2.7 billion and EBIT increasing to $1.3 billion, underpinned by robust execution across all segments and effective cost management.

Key takeaways

EBITDA increased sequentially to $2.7 billion, and EBIT rose to $1.3 billion.
Logistics & Services improved EBIT margin from 4.8% to 5.5%, driven by asset utilization and cost management.
Ocean reported a 7% year-on-year volume growth, achieving over 90% reliability and significant cost savings following the Gemini implementation.
Terminal operations delivered record revenues and profitability, with return on invested capital rising to 17.2%.
Full-year EBIT guidance narrowed to $3 billion - $3.5 billion, reflecting sustained demand growth, particularly from China.

View recap

Amylyx Pharmaceuticals Inc. Common Stock

AMLX Q3 2025

Reported: 2025-11-08

Amylyx Pharmaceuticals recorded significant progress in Q3 2025, highlighted by the continued advancement of its lead drug avexitide for post-bariatric hypoglycemia, while strengthening its financial position with a cash balance of $344 million.

Key takeaways

Avexitide, granted FDA breakthrough therapy designation, aims to address the unmet need in post-bariatric hypoglycemia with a pivotal Phase III trial set to complete recruitment by Q1 2026.
Cash position strengthened to $344 million following a successful public offering, positioning the company for a potential drug launch in 2027.
Positive participant engagement and motivation reported in clinical trials, reinforcing the significant demand for effective treatment options.
AMX0035 for Wolfram syndrome and AMX0114 for ALS remain on track, with pivotal study plans and preliminary data expected in the coming year.

View recap

Amadeus IT Group, S.A.

AMS.MC Q3 2025

Reported: 2025-11-08

Amadeus reported a robust third quarter with 8% revenue growth and 9% adjusted EBIT improvement year-to-date, underscoring its strategic positioning in the travel technology market.

Key takeaways

Strong customer acquisition, highlighted by a new partnership with Ascott Limited for its Central Reservation System, expands Amadeus' footprint in hospitality.
Continued investment in AI and R&D, exceeding EUR 1 billion, positions Amadeus to leverage technology for enhanced operational efficiency and personalized customer experiences.
The rollout of the Nevio platform is gaining traction, with successful implementations like Finnair's launch of native ancillary combos, strengthening competitive advantage in airline retailing.
Amadeus is enhancing its travel platform by increasing agreements with travel sellers and expanding offer content, aiming to become the primary aggregator of NDC (New Distribution Capability) content in the industry.
Progress in strategic partnerships with Microsoft and Google is driving AI innovation, enabling better decision-making tools such as the new Garv AI agent for airport operations.

View recap

Arlo Technologies, Inc.

ARLO Q3 2025

Reported: 2025-11-08

Arlo Technologies delivered a record-breaking Q3 2025, driven by exceptional growth in paid accounts and robust SaaS performance, culminating in significant revenue and profitability milestones.

Key takeaways

Added 281,000 paid accounts, exceeding targets, bringing total to 5.4 million, up 27% year-over-year.
Annual recurring revenue reached $323 million, a 34% increase year-over-year, with service gross margin expanding to over 85%.
Adjusted EBITDA surged 50% from the prior year to $17 million, and GAAP EPS reached a record $0.07.
Successfully executed the largest product launch in company history, contributing to nearly 30% unit sales growth year-over-year.
Anticipating 20% to 30% unit growth in Q4, positioned well for continued service revenue growth into 2026.

View recap

AdvanSix Inc.

ASIX Q3 2025

Reported: 2025-11-08

AdvanSix reported a challenging third quarter in 2025, with revenues declining 6% year-over-year to $374 million amid soft demand for nylon and chemical intermediates, while strategic cash management remains a priority.

Key takeaways

Adjusted EBITDA fell to $25 million, down $28 million from last year, primarily due to reduced acetone price spreads and increased utility costs.
Production was moderated in response to downward demand trends, particularly in nylon solutions and chemical intermediates, with an expected $7 million to $9 million impact on Q4 EBITDA due to operational disruptions.
Strong performance in plant nutrients, aided by a favorable sales mix and stable pricing, highlights continued growth in sulfur nutrition demand, projected at 3-4% annually.

View recap

AerSale Corporation

ASLE Q3 2025

Reported: 2025-11-08

AerSale Corp. reported third-quarter revenue of $71.2 million, reflecting a 13.5% year-over-year decline primarily due to the absence of whole asset sales, though the core business exhibited solid growth of 18.5%.

Key takeaways

Adjusted EBITDA improved to $9.5 million (13.3% of sales) from $8.2 million (10.0% of sales) year-over-year, driven by better leasing contributions and cost reduction initiatives.
Asset Management segment revenue grew nearly 40.9% excluding whole asset transactions, fueled by strong USM volume and leasing activity, with 15 engines and 1,757 freighter aircraft now under lease.
The company maintains a robust feedstock inventory of $371.1 million, ensuring a solid foundation for future growth amid limited market supply.
TechOps segment revenue remained stable, bolstered by increased sales of component parts, with ongoing discussions for long-term contracts to enhance volume visibility.
Progress on the 757 passenger to freighter conversion program continues, with one aircraft currently leased and plans for additional placements underway, reflecting heightened market interest.

View recap

Avino Silver & Gold Mines Ltd.

ASM Q3 2025

Reported: 2025-11-08

Avino Silver & Gold Mines reported a strong Q3 2025 performance, showcasing significant operational advancements and financial health with a notable revenue increase and improved cash position.

Key takeaways

Revenues rose 44% year-over-year to $21 million, driven by enhanced mill performance and operational efficiency.
Achieved record cash of $57 million and working capital of $51 million, reflecting a robust balance sheet.
Successfully acquired outstanding royalties on La Preciosa, improving project economics and reducing operational complexity.
Positive drill results from La Preciosa indicate higher potential resource grades, reinforcing exploration efforts.
Recognized among the top-performing companies on the TSX 2025 TSX30, with a share price increase of 610% over 3 years.

View recap

Avino Silver & Gold Mines Ltd.

ASM.TO Q3 2025

Reported: 2025-11-08

Avino Silver & Gold Mines achieved a strong Q3 in 2025, marked by a 44% revenue increase and continued operational improvements, underscoring its transformational growth strategy in the precious metals sector.

Key takeaways

Generated $21 million in revenue, a 44% increase year-over-year.
Maintained a strong financial position with record cash reserves of $57 million and working capital of $51 million.
Successfully processed La Preciosa material ahead of schedule, consolidating project ownership to enhance operational efficiency and reduce complexity.
Drilled positive results at La Preciosa, including high-grade silver and gold intercepts, signaling significant resource potential.
Ranked fifth in the TSX30 and added to major indexes, reflecting robust market recognition and share price growth of 610% over the past three years.

View recap

American States Water Company

AWR Q3 2025

Reported: 2025-11-08

American States Water Company reported strong third-quarter earnings, with EPS rising 11.6% year-over-year to $1.06, driven by favorable regulatory outcomes and increased construction activities.

Key takeaways

Consolidated revenue increased by $21 million, aided by new rates from regulatory decisions impacting both water and electric segments.
Earnings from American States Utility Services rose by 72.7% to $0.19 per share, reflecting heightened construction activity.
The company is on track to invest $180 million to $210 million in utility infrastructure this year, bolstering long-term growth potential.
American States Water was recognized in Time's America’s Best Midsize Companies 2025 and Barron’s 100 Most Sustainable Companies, highlighting its strong performance in growth and sustainability.

View recap

AstraZeneca PLC

AZN Q3 2025

Reported: 2025-11-08

AstraZeneca continues its strong growth trajectory, reporting an 11% revenue increase year-to-date, fueled by robust demand for its innovative drugs and significant advancements in its pipeline.

Key takeaways

Core EPS rose by 15%, reflecting sustained operational momentum.
The company achieved 31 regulatory approvals this year, underscoring an accelerating pipeline.
Growth was broad-based, with oncology revenue up 16% and substantial advances in Biopharmaceuticals and Rare Diseases.
AstraZeneca secured a landmark pricing agreement in the U.S., expected to enhance accessibility and market stability.
Strong performance across key geographies, particularly the U.S. and emerging markets, which saw revenue increases of 11% and 21%, respectively.

View recap

AstraZeneca PLC

AZN.L Q3 2025

Reported: 2025-11-08

AstraZeneca delivered strong results for the first nine months of 2025, with total revenue increasing by 11% and core EPS up 15%, supported by robust demand across its diverse portfolio and significant regulatory achievements.

Key takeaways

Achieved 31 regulatory approvals this year and positive results from 16 Phase III trials, underscoring strong pipeline momentum.
Oncology franchise grew by 16%, while biopharmaceuticals and rare diseases increased by 8% and 6%, respectively, driven by newer product launches.
Landmark agreement with the U.S. government will reduce prescription medicine costs while enhancing pricing clarity and protections for future innovations.
Expansion of U.S. manufacturing capabilities, including a new facility in Virginia, supports long-term growth ambitions.
Proposed harmonization of share listings will improve capital access and shareholder participation in AstraZeneca's future growth.

View recap

Bridger Aerospace Group Holdings, Inc. Common Stock

BAER Q3 2025

Reported: 2025-11-08

Bridger Aerospace delivered an exceptional performance in Q3 FY2025, exceeding annual revenue guidance and showing significant operational enhancements amid a challenging wildfire season.

Key takeaways

Record task orders and nearly 10% year-over-year increase in fleet utilization, with multi-mission aircraft flight hours nearly doubling.
Adjusted EBITDA guidance remains on track, supported by strategic long-term contracts with the Forest Service and states.
Completed a $49 million sale leaseback and secured a $331 million expanded debt facility, enhancing financial flexibility for growth and acquisitions.
FMS division generated $2.4 million, navigating delays due to federal budgeting but positioned for growth in defense and commercial opportunities.
Ignis Technologies' mobile platform enhances operational effectiveness, with live streaming capabilities successfully utilized during active fire incidents.

View recap

Brookfield Asset Management Ltd.

BAM.TO Q3 2025

Reported: 2025-11-08

Brookfield Asset Management delivered robust third-quarter results with record fundraising of $30 billion, driving a 17% increase in fee-related earnings and strong deployment across diverse global markets.

Key takeaways

Fee-related earnings increased by 17% year-over-year to $754 million, while distributable earnings rose 7% to $661 million.
Total inflows exceeded $100 billion over the past year, marking the highest pace of organic fundraising in the company's history.
Successfully raised capital for flagship funds and strategic ventures, with significant growth in credit capabilities through the acquisition of Oaktree Capital Management.
A favorable market environment fueled a 25% increase in global M&A activity, enhancing deployment opportunities and asset monetization.
Strong balance sheet with expanding margins positions Brookfield for continued growth heading into 2026.

View recap

Barings BDC, Inc.

BBDC Q3 2025

Reported: 2025-11-08

Barings BDC reported strong net investment income for Q3 2025, demonstrating robust portfolio performance and effective strategic positioning in the middle market despite ongoing market volatility.

Key takeaways

Net investment income increased to $0.32 per share, up from $0.28 in the previous quarter.
The portfolio's net asset value per share stood at $11.10, with 95% of assets from Barings-originated positions.
Fourth-quarter dividend declared at $0.26 per share, yielding 9.4% on net asset value.
Continued focus on senior secured financing solutions in defensive noncyclical sectors provides resilience and stability.
Leadership transition set for January 2026, with Tom McDonnell succeeding Eric Lloyd as CEO, ensuring continuity in strategic direction.

View recap

Franklin Resources, Inc.

BEN Q4 2025

Reported: 2025-11-08

Franklin Resources reported strong momentum in its fiscal 2025 results, achieving key strategic milestones and recognition as Asset Manager of the Year, reflecting solid growth in its alternative investment business.

Key takeaways

Over 50% of mutual funds, ETFs, and composites outperformed peers and benchmarks, enhancing investment performance across public markets.
The acquisition of Apera Asset Management increased private credit AUM to $95 billion, significantly bolstering Franklin’s capabilities in European markets.
The firm raised $22.9 billion in private market fundraising, on track to reach a 5-year goal of $100 billion, with expectations for fiscal 2026 to see fundraising increase to $25–30 billion.
Franklin's wealth management offerings are gaining traction, now contributing over 20% to private market fundraising and expected to rise to 25-30% in the coming years.

View recap

Blend Labs, Inc.

BLND Q3 2025

Reported: 2025-11-08

Blend Labs, Inc. posted solid financial results in Q3 2025, recording its fifth consecutive quarter of non-GAAP operating profitability, underscoring strong execution amidst a strategic shift towards higher-margin services.

Key takeaways

Total revenue remained steady, influenced by growth in the Consumer Banking Suite, while the mortgage segment faced headwinds due to strategic transitions.
The company signed 14 new deals, including a significant 7-figure expansion with a top U.S. bank, indicating strong demand for its platform solutions.
Blend’s customer pipeline is robust, up approximately 60% year-over-year, with multiple high-value opportunities across consumer banking and mortgage sectors.
Transitioning from low-margin legacy customers to higher-margin partnerships is yielding a healthier business model, despite minor churn.
Enhanced focus on integrating AI into lending processes positions Blend favorably to address industry cost challenges and improve operational efficiencies.

View recap

Compania Cervecerias Unidas S.A.

CCU Q3 2025

Reported: 2025-11-08

CCU's Q3 2025 results show resilience with a 4.6% increase in consolidated EBITDA, bolstered by improvements in Chile, despite facing challenges in the international business segment, particularly in Argentina.

Key takeaways

Consolidated net sales decreased by 1.1%, impacted by a 2.2% drop in average prices, although volume growth of 1.2% partially mitigated this decline.
EBITDA margin expanded by 60 basis points, reflecting operational efficiencies and improved gross margins in key segments.
The International Business segment experienced an 8.9% decline in net sales, primarily due to a significant currency devaluation in Argentina, while growth in volume was noted, especially in the water category.
The Wine Operating segment's EBITDA decreased by 12%, driven by a decline in domestic sales and increased costs, despite positive export performance.
Year-to-date EBITDA growth of 9.9%, excluding nonrecurring gains, underscores the effectiveness of CCU's 2025-2027 strategic plan focusing on profitability through revenue management and efficiency improvements.

View recap

Constellation Energy Corporation

CEG Q3 2025

Reported: 2025-11-08

Constellation Energy Corporation reported robust third-quarter results, achieving adjusted operating earnings of $3.04 per share, driven by strong performance in its commercial and generation segments and an increasingly favorable market for nuclear energy.

Key takeaways

GAAP earnings reached $2.97 per share, reflecting year-over-year growth and strong operational reliability from nuclear plants.
Landmark agreement reached in Maryland ensures the continued operation of Conowingo Dam for 50 years, benefiting clean energy initiatives.
Progress in the data economy suggests a more mature and sophisticated customer base, enhancing transaction dynamics.
Pending approval for the Calpine acquisition remains on track, positioning Constellation for expanded coast-to-coast solutions.
Growing public support for nuclear energy further strengthens the company's strategic positioning in the market.

View recap

Cerus Corporation

CERS Q3 2025

Reported: 2025-11-08

Cerus Corporation delivered solid third-quarter performance, continuing its momentum with significant growth in INTERCEPT adoption and steady advancements in both clinical development and operational execution.

Key takeaways

INTERCEPT adoption in the U.S. has risen to approximately 60%, with potential to exceed 80% as the product's value proposition improves.
Recent selection by the German Red Cross for a key study reinforces INTERCEPT's growing acceptance as the standard of care in platelet treatments.
Cerus completed enrollment for the Phase III RedeS trial in the U.S. for red blood cells, anticipating crucial results in 2026.
Continued focus on achieving positive non-GAAP adjusted EBITDA for the full year 2025, highlighting operational efficiency.
Planned PMA submission for the next-generation LED-based INT200 device is on track for mid-2026, aiming to enhance platelet shelf life.

View recap

IES Holdings, Inc.

CF Q3 2025

Reported: 2025-11-08

CF Industries reported a robust Q3 2025, delivering adjusted EBITDA of $2.1 billion and achieving a 25% reduction in greenhouse gas emissions intensity, aligning with its strategic decarbonization goals.

Key takeaways

Achieved a trailing 12-month recordable incident rate of 0.37, reflecting strong safety performance.
Completed significant operational improvements including closing high-emission plants and enhancing production efficiency in others, with IRRs exceeding 20%.
Set to develop the world’s largest ultra-low emissions ammonia plant in partnership with JERA and Mitsui.
Maintained strong free cash flow generation and aggressive share repurchase program, despite trading at low valuation multiples compared to industry peers.
Positioned for continued high returns through GHG reduction initiatives and strong nitrogen demand dynamics.

View recap

Coherus BioSciences, Inc.

CHRS Q3 2025

Reported: 2025-11-08

Coherus Oncology reported strong Q3 2025 results, demonstrating significant progress in both financial metrics and clinical development, particularly with its promising pipeline of cancer therapies.

Key takeaways

Revenue growth, driven by LOQTORZI’s successful market performance in nasopharyngeal cancer, reinforces confidence in achieving future revenue targets.
The company has improved its balance sheet and reduced expenses, reflecting effective cost management and strategic financial planning.
Enrollment in clinical trials is progressing well, with promising indications in multiple cancer types, setting the stage for data readouts planned for next year.
Coherus is focusing on partnerships to enhance clinical development funding and expand the reach of its innovative Treg-depleting therapies, leveraging global rights for key assets.
Continued advancements in Treg-targeting treatments, especially CHS-114, position Coherus at the forefront of emerging cancer therapies, following significant recognition at industry events.

View recap

Curis, Inc.

CRIS Q3 2025

Reported: 2025-11-08

Curis continues to make significant strides in its clinical studies, particularly with emavusertib for hard-to-treat lymphomas, while reducing its net losses year-over-year.

Key takeaways

Curis reported a narrower net loss of $7.7 million for Q3 2025, down from $10.1 million in Q3 2024, reflecting improved operational efficiency.
Research and development expenses decreased to $6.4 million in Q3 2025, driven by lower clinical and manufacturing costs.
The company is poised to support accelerated submission for its emavusertib study in both the U.S. and Europe following strong interest from regulatory bodies.
Initial results from the AML triplet study show promising disease response rates, with MRD conversion seen in 50% of evaluable patients.
Curis' cash position remains stable at $9.1 million, expected to fund operations into 2026 amidst ongoing clinical trials.

View recap

Claritev Corporation

CTEV Q3 2025

Reported: 2025-11-08

Claritev Corporation reported a strong Q3 2025, delivering higher-than-expected revenue and adjusted EBITDA growth, reaffirming the successful execution of its strategic turnaround ahead of schedule.

Key takeaways

Revenue increased by 6.7% and adjusted EBITDA grew by 9.5%, both surpassing internal projections.
The company renewed contracts with its top 10 clients, providing stability and a solid foundation for growth.
Added 5 new logos and closed $15 million in Annual Contract Value, with a 25% increase in average ACV per transaction.
Significant growth across all six focused market verticals, indicating effective alignment and execution of strategic priorities.
Pipeline growth reflected a 67% increase year-to-date, showcasing a robust expansion strategy in new client acquisition and existing client value enhancement.

View recap

CytomX Therapeutics, Inc.

CTMX Q3 2025

Reported: 2025-11-08

CytomX Therapeutics reported robust progress in its third quarter 2025 results, with encouraging interim Phase I data for its colorectal cancer drug candidate, CX-2051, demonstrating significant clinical activity and a well-tolerated safety profile.

Key takeaways

CX-2051, targeting EpCAM in colorectal cancer, showed meaningful tumor reductions and a promising median progression-free survival of 5.8 months.
The drug was generally well tolerated, with no significant safety issues, implying effective use of CytomX's proprietary masking technology.
The company aims to expand the Phase I study to about 100 patients and initiate a Phase Ib study with bevacizumab in Q1 2026, enhancing treatment potential.
A strategic addition to the team, Rachael Lester as Chief Business Officer, is expected to bolster corporate development efforts.
CytomX remains committed to addressing unmet needs in oncology, with ambitions to establish CX-2051 as a new standard of care in late-stage colorectal cancer.

View recap

CareTrust REIT, Inc.

CTRE Q3 2025

Reported: 2025-11-08

CareTrust REIT delivered robust third-quarter results with normalized FFO per share growing 18% year-over-year to $0.45, supported by a historic $1.6 billion in year-to-date investments and strategic expansions into new growth areas.

Key takeaways

Closed $495 million in new investments during Q3, driving total year-to-date investments to over $1.6 billion.
Third-quarter normalized FFO per share of $0.45 reflects a strong 18% increase compared to the same quarter last year.
Integration of a U.K. acquisition is progressing well, with new opportunities now comprising one-third of the current $600 million deal pipeline.
Positioned to launch a third growth engine in Senior Housing Operating Properties (SHOP) with expectations to close the first deal by year-end.
Strengthened balance sheet with zero near-term debt maturities until 2028, enhancing liquidity for future investments.

View recap

Curaleaf Holdings, Inc.

CURLF Q3 2025

Reported: 2025-11-08

Curaleaf Holdings reported a stable third quarter with $320 million in revenue, showcasing resilience amidst price compression while achieving significant growth in its international segment.

Key takeaways

Revenue increased by 2% sequentially, with the international segment experiencing robust 12% sequential growth and 56% year-over-year growth.
Adjusted gross margins improved to 50%, reflecting a 115 basis point increase, while adjusted EBITDA stood at $69 million, yielding a 22% margin.
The company strengthened its balance sheet by closing a $100 million revolving credit line, providing enhanced operational flexibility.
Average flower potency surpassed 30% for the first time, aided by improved cultivation techniques and genetics.
The launch of innovative products such as the Anthem pre-roll brand is gaining traction, significantly contributing to sales and brand awareness.

View recap

Docebo Inc.

DCBO Q3 2025

Reported: 2025-11-08

Docebo delivered strong Q3 2025 results with a notable 14% year-over-year growth in its core business, driven by improved mid-market performance and effective leadership changes.

Key takeaways

Annual recurring revenue (ARR) rose by $2.5 million sequentially, indicating strong underlying business momentum.
The company achieved significant wins in the federal sector ahead of expectations following its FedRAMP listing, acquiring new clients including the Department of Energy.
Core business retention improved, reflecting enhanced customer satisfaction and loyalty.
Record mid-market performance driven by strategic changes within the leadership team and improved operational processes.
Continued diversification in public sector engagements mitigates risks associated with government shutdowns, maintaining a robust pipeline for future growth.

View recap

Datadog, Inc.

DDOG Q3 2025

Reported: 2025-11-08

Datadog's Q3 2025 results exceeded expectations, driven by robust demand amid cloud migration, showcasing strong revenue growth and enhanced customer engagement across its product suite.

Key takeaways

Revenue reached $886 million, a 28% year-over-year increase, above guidance expectations.
Customer base expanded to approximately 32,000, with significant growth in high-value accounts generating 89% of ARR.
Free cash flow stood at $214 million, reflecting a 24% margin, underscoring strong operational efficiency.
Adoption of multi-product usage increased, with 84% of customers using two or more products and steady growth in digital experience and security offerings.
Enthusiastic feedback for AI innovations, particularly the new Bits AI agents, indicates high customer interest and potential for operational transformation.

View recap

Ginkgo Bioworks Holdings Inc. Class A Common Stock

DNA Q3 2025

Reported: 2025-11-08

Ginkgo Bioworks reported a significant reduction in cash burn and reaffirmed its 2025 revenue guidance, despite a challenging environment in the biotechnology sector.

Key takeaways

Quarterly cash burn decreased by 75% year-over-year to $28 million, significantly improving the company's cash position with $462 million in cash and no bank debt.
Cell Engineering revenue fell 61% year-over-year to $29 million due to a previous noncash revenue spike; adjusted revenue was down only 11% compared to the prior year.
Biosecurity revenue reached $9 million with a gross margin of 19%, and segment operating loss improved by 21% from a year prior.
The company remains focused on expansion in AI and automation, with plans to deliver autonomous labs at customer sites.
Ginkgo reaffirmed its full-year 2025 revenue guidance between $167 million and $187 million, with expectations for Cell Engineering revenue to range from $117 million to $137 million.

View recap

Direct Digital Holdings Inc. Class A Common Stock

DRCT Q3 2025

Reported: 2025-11-08

Direct Digital Holdings reported third-quarter 2025 revenue of $8 million, a decline from the prior year driven by lower sell-side performance, though buy-side operations saw a 7% increase, highlighting strategic growth amidst challenges.

Key takeaways

Buy-side revenue rose to $7.3 million, constituting the majority of total revenue.
Sell-side revenue fell to $600,000, primarily due to reduced impression inventory impacting engagement levels.
The company launched a partnership with ReachTV to enhance offerings, focusing on targeted advertising for the travel sector.
Year-to-date, operating expenses decreased by approximately 20%, reflecting ongoing cost management efforts.
Integration of AI tools in operations is driving innovation and efficiency, with significant improvements in development timelines and operational costs.

View recap

DiamondRock Hospitality Company

DRH Q3 2025

Reported: 2025-11-08

DiamondRock Hospitality's Q3 2025 results surpassed expectations, driven by strong out-of-room revenue growth and effective cost management, despite a slight decline in RevPAR.

Key takeaways

Corporate adjusted EBITDA reached $79.1 million, while adjusted FFO per share was $0.29, exceeding projections.
Out-of-room revenues increased by 5.1%, contributing to a total RevPAR growth of 1.5%.
Urban properties achieved RevPAR growth of 0.6%, with strong performance noted in September, highlighting a recovery trend.
Successful refinancing efforts have led to a fully unencumbered portfolio, improving financial flexibility.
The company continues to repurchase shares and expects a quarterly dividend consistent with a reduced payout ratio, targeting sustainable capital allocation.

View recap

Duke Energy Corporation

DUK Q3 2025

Reported: 2025-11-08

Duke Energy reported third-quarter adjusted earnings per share of $1.81, reflecting an 11% year-over-year growth, driven by robust retail sales and strategic investment in generation capacity.

Key takeaways

Adjusted EPS rose to $1.81 compared to $1.62 in Q3 2024, affirming the company's strong performance trajectory.
Narrowed full-year guidance to a range of $6.25 to $6.35, indicating confidence in meeting financial targets.
Planned capital investments of $95 billion to $105 billion over the next five years support the addition of over 13 gigawatts of new generation capacity.
Continued focus on affordability with rate changes below inflation, enhancing customer value and positioning for long-term growth.
Economic impact of the 10-year plan projected at $370 billion, supporting nearly 170,000 jobs annually in communities served.

View recap

DoubleVerify Holdings, Inc.

DV Q3 2025

Reported: 2025-11-08

DoubleVerify's Q3 2025 results showcase robust revenue growth and strong operational margins, driven by innovative AI solutions and steady demand from key verticals despite softer retail budgets.

Key takeaways

Revenue reached $189 million, reflecting an 11% year-over-year increase and exceeding guidance.
Adjusted EBITDA margin improved to 35%, highlighting the scalable efficiency of DV's business model.
Strong adoption of the AI-powered DV Authentic AdVantage solution generated approximately $8 million in annual contract value shortly after launch.
Customer retention remained exemplary with 0% churn among the top 100 customers, underscoring stability in major accounts.
Diversification into social and CTV sectors is enhancing revenue resilience and positioning the company for sustained growth into 2026.

View recap

DXP Enterprises, Inc.

DXPE Q3 2025

Reported: 2025-11-08

DXP Enterprises delivered robust Q3 2025 results with total sales up 8.6% year-over-year, propelled by strong demand across key segments and a notable 11% adjusted EBITDA margin.

Key takeaways

Total revenue reached $513.7 million, driven by significant growth in Innovative Pumping Solutions (up 11.9%) and Service Centers (up 10.5%).
Year-to-date sales increased 11.8%, while adjusted EBITDA rose 17.6%, affirming the effectiveness of growth strategies and operational resilience.
Gross profit margins improved to 31.4%, a 50 basis point increase compared to the previous year, demonstrating ongoing efficiency enhancements.
Supply Chain Services experienced a decline of 5% year-over-year; however, demand is expected to rebound as new customer implementations gain traction into 2026.
Continued focus on acquisitions and organic growth positions DXP favorably for future expansion as the fiscal year concludes and enters 2026.

View recap

Eventbrite, Inc.

EB Q3 2025

Reported: 2025-11-08

Eventbrite's Q3 2025 performance met revenue expectations with solid progress in operational metrics, demonstrating a stabilization in paid ticket volumes and creator activity, setting the stage for growth in 2026.

Key takeaways

Q3 net revenue reached $71.7 million, with a 38% year-over-year growth in Eventbrite Ads revenue.
Adjusted EBITDA margin improved to 11.7%, exceeding guidance of 7%, due to effective cost management.
New paid creator acquisition increased by nearly 4%, alongside enhanced creator retention, indicating a healthier marketplace.
The company is focusing on enhancing user experience and implementation of AI to improve event creation and marketing for creators.
Ongoing efforts to optimize operations aim to drive revenue and margin expansion as Eventbrite builds momentum heading into 2026.

View recap

Ellington Financial Inc.

EFC Q3 2025

Reported: 2025-11-08

Ellington Financial achieved a robust third quarter, reporting a GAAP net income of $0.29 per share and an adjustable distributable earnings (ADE) of $0.53 per share, marking a new quarterly high. The company's strategic growth initiatives and robust securitization activity significantly strengthened its balance sheet and portfolio.

Key takeaways

GAAP net income of $0.29 per share and record ADE of $0.53 per share exceeded quarterly dividends of $0.39 per share.
Securitization activity reached a record of seven deals in the quarter, contributing to a total of 20 year-to-date, over three times last year’s pace.
Portfolio holdings expanded by 12% driven by growth in proprietary reverse mortgages, non-QM loans, and commercial mortgage bridge loans.
Successfully priced $400 million of 5-year senior unsecured notes, enhancing long-term financing options and reducing reliance on short-term debt.
Continued strong credit performance with only 13 basis points of cumulative realized credit losses on $14.7 billion in residential mortgage loan fundings.

View recap

Emera Incorporated

EMA.TO Q3 2025

Reported: 2025-11-08

Emera reported strong third-quarter results with adjusted earnings per share of $0.88, marking a nearly 9% year-over-year increase, driven by strategic capital investments and consistent execution.

Key takeaways

Achieved five consecutive quarters of adjusted earnings growth, with year-to-date earnings per share of $2.94, up 14% from last year.
Announced a 1% dividend increase, marking the 19th consecutive year of annual dividend growth.
Set a record capital investment of $3.6 billion for 2025, with over $2.6 billion already deployed in key projects across the business.
Plans to invest $20 billion from 2026 to 2030, with a strong focus on enhancing reliability and meeting increased demand in Florida's growing market.
Regulatory clarity achieved through recent settlements, supporting ongoing rate base growth projected at 8% to 9% through 2030.

View recap

EverCommerce Inc. Common Stock

EVCM Q3 2025

Reported: 2025-11-08

EverCommerce delivered robust third-quarter results, achieving a 5.3% year-over-year revenue growth and successfully expanding its adjusted EBITDA margin to 31.5%. The company also strategically acquired ZyraTalk to enhance its AI capabilities.

Key takeaways

Revenue reached $147.5 million, aligning with guidance and marking a 5.3% increase year-over-year.
Adjusted EBITDA of $46.5 million exceeded expectations, showcasing a 140 basis point margin improvement from the previous year.
Payments revenue grew 6% year-over-year, accounting for 21% of overall revenue, driven by an emphasis on enablement and customer engagement.
Completed the sale of the marketing technology solutions segment to Ignite Visibility, allowing a sharper focus on core SaaS and payments businesses.
Annualized total payments volume expanded to approximately $13 billion, reflecting ongoing investments in product and market strategies.

View recap

Fomento de Construcciones y Contratas, S.A.

FCC.MC Q3 2025

Reported: 2025-11-08

The company's latest earnings report reflects a notable increase in turnover across its environmental and water divisions, despite challenges from currency fluctuations and the impact of discontinued activities on net profits.

Key takeaways

Environment unit revenues rose by 11.5% to EUR 3.4 billion, driven by new contracts and strategic acquisitions.
Aqualia's turnover increased by 8.7% to EUR 1.5 billion, with significant growth reported in Spain and Central Europe.
The attributable net profit declined, influenced by the EUR 148.6 million from discontinued activities and adverse exchange rate impacts.
EBITDA for the environment unit grew 11% to over EUR 500 million, maintaining stable margins at 15.6%.
Strong operational performance noted in the U.S. and U.K. platforms, with revenues increasing significantly in both regions.

View recap

Fidus Investment Corporation

FDUS Q3 2025

Reported: 2025-11-08

Fidus Investment Corporation reported solid performance in Q3 2025, with adjusted net investment income (NII) of $0.50 per share, exceeding its base dividend significantly, while net asset value increased by 2.7%.

Key takeaways

Adjusted NII of $0.50 per share comfortably covered the base dividend of $0.43, with total dividends paid reaching $0.57 per share, including a supplemental dividend.
Net asset value rose to $711 million, reflecting strong portfolio management and growth, with a fair value equal to 102% of cost.
Portfolio composition remains robust, with 82% in first lien investments and sound credit quality, maintaining less than 1% of the portfolio on nonaccrual.
Originations totaled $74.5 million, primarily through add-on investments supporting M&A activities, positioning the company for sustained growth in Q4.
Management remains focused on capital preservation and generating attractive risk-adjusted returns amid a positive outlook for market conditions.

View recap

Fulgent Genetics, Inc.

FLGT Q3 2025

Reported: 2025-11-08

Fulgent Genetics reported strong third-quarter results for 2025, showcasing robust growth in laboratory services and significant progress in its therapeutic development pipeline.

Key takeaways

Laboratory services revenue reached nearly $84 million, with a year-over-year growth of 16.4% driven by the Precision Diagnostics and Biopharma segments.
Fulgent is raising its outlook for 2025, reflecting sustained business momentum and successful integration of AI technologies in its operations.
Phase II trials for lead candidate FID-007 demonstrated meaningful efficacy in treating recurrent or metastatic head and neck cancer, with overall response rates of 51%.
FID-022 has entered Phase I trials, targeting multiple solid tumors, indicating an expanding and diversified pipeline.
The company continues to enhance diagnostic services, recently launching a rapid whole genome sequencing offering that provides preliminary results within 48 hours.

View recap

FS KKR Capital Corp.

FSK Q3 2025

Reported: 2025-11-08

FS KKR Capital Corp. reported stable Q3 2025 performance, with net investment income aligning closely with guidance and a slight increase in net asset value. The company remains optimistic about its dividend strategy amidst a favorable interest rate environment.

Key takeaways

Q3 net investment income was $0.57 per share, matching expectations and reflecting resilience in a volatile market.
Net asset value increased to $21.99, indicating strong portfolio health.
A Q4 distribution of $0.70 per share was declared, with plans for a competitive annualized yield of approximately 10% for 2026.
M&A activity is on the rise, with deal evaluations up 30% year-over-year, signaling positive market momentum.
The company anticipates continued attractiveness in current income streams despite fluctuations in net investment income moving forward.

View recap

GigaCloud Technology Inc Class A Ordinary Shares

GCT Q3 2025

Reported: 2025-11-08

GigaCloud Technology reported robust Q3 2025 results with a 10% year-over-year revenue increase, achieving record quarterly revenues of $333 million and EPS of $0.99. The company's strategic focus on M&A and diversification has strengthened its market position despite macroeconomic challenges.

Key takeaways

Quarterly revenue grew 10% year-over-year to $333 million, marking a return to double-digit growth.
Marketplace GMV increased by 21% over the past 12 months, reaching nearly $1.5 billion, indicating strong scalability.
International markets, particularly Europe, drove growth with a 70% revenue increase, highlighting effective diversification strategies.
The acquisition of Noble House has revitalized the portfolio, with new product optimizations returning it to profitability.
GigaCloud announced plans to acquire New Classic Home Furnishing, aimed at expanding brick-and-mortar market presence and further diversifying offerings.

View recap

Globus Medical, Inc.

GMED Q3 2025

Reported: 2025-11-08

Globus Medical reported a robust Q3 2025, with sales increasing 22.9% to $769 million and non-GAAP EPS jumping 42.6% to $1.18, driven by strong growth in both the U.S. and international spine markets.

Key takeaways

Base business revenue rose to $669.8 million, with an adjusted EBITDA margin improvement of 435 basis points to 35.3%.
Free cash flow reached a record $213.9 million, underlining operational efficiency and strong cash generation.
The U.S. Spine segment grew by 9.6%, maintaining positive momentum with 32 consecutive weeks of growth.
The recently acquired Nevro business contributed $99.3 million in revenue, enhancing overall business expansion.
Strategic share repurchases totaled $40 million during the quarter, reflecting confidence in long-term growth and shareholder value.

View recap

GoPro, Inc.

GPRO Q3 2025

Reported: 2025-11-08

GoPro's Q3 2025 performance exceeded revenue expectations with the successful launch of three new hardware products, positioning the company for profitable growth in 2026.

Key takeaways

Launched three innovative products, including the MaX2 360-camera, which opens a new growth segment with an estimated TAM of nearly 2 million units annually.
Achieved positive early customer feedback for MaX2, praised for superior image quality and versatility, enhancing competitive positioning in the 360-camera market.
Expanded product line offers 8 camera models and numerous accessories, setting the stage for holiday sales and broader market appeal.
Subscription model continues to drive value, with renewed growth anticipated in 2026 alongside the camera unit growth and software updates.

View recap

Grindr Inc. Common Stock

GRND Q3 2025

Reported: 2025-11-08

Grindr reported robust earnings for Q3 2025, with a 30% year-over-year revenue growth and an impressive adjusted EBITDA margin of 47%. The company is poised for a strong finish to the year while reaffirming its growth outlook.

Key takeaways

Adjusted EBITDA forecast for full year 2025 is raised to $191-$193 million, with margins exceeding 43%.
Successful pricing tests for new subscription tiers showed minimal user retention impact, indicating strong customer loyalty.
Continued product expansion and feature enhancements, including AI-powered tools, are driving user engagement and revenue growth.
A unique demographic influx keeps the platform vibrant, particularly with strong engagement among users aged 18-29.
The Board is evaluating a proposal from two major shareholders to take Grindr private, while the company focuses on executing its strategic vision.

View recap

GrowGeneration Corp.

GRWG Q3 2025

Reported: 2025-11-08

GrowGeneration reported strong Q3 2025 results, achieving net sales of $47.3 million and positive adjusted EBITDA of $1.3 million, driven by a robust increase in proprietary brand revenues and substantial cost reductions.

Key takeaways

Sequential net sales growth of 15.4% and a significant gross margin expansion to 27.2%.
Proprietary brands now account for 31.6% of cultivation revenue, up from 23.8% year-over-year, with Char Coir and Drip Hydro leading growth.
Completed $7 million in cultivation infrastructure projects, positioning the company for ongoing revenue contributions from commercial and craft operators.
Expanded distribution partnerships, including with Arett Sales, enhancing reach into thousands of stores across 32 states.
Strong balance sheet with $48.3 million in cash and no debt, supporting future growth and operational investments.

View recap

Goldman Sachs BDC, Inc.

GSBD Q3 2025

Reported: 2025-11-08

Goldman Sachs BDC, Inc. reported strong performance in Q3 2025, marked by heightened investment activity amid a recovering macroeconomic environment, though NAV per share saw a modest decline.

Key takeaways

New investment commitments reached $470.6 million, the highest since Q4 2021, with 100% in first lien loans.
Q3 net investment income per share was $0.40, while net asset value per share decreased slightly to $12.75.
A supplemental dividend of $0.04 per share was declared, with a fourth quarter base dividend set at $0.32.
The company remains prudent in credit selection, benefiting from proximity to Goldman Sachs’ investment banking franchise in evaluating opportunities.
Overall risk dynamics in the private credit space are being closely monitored, with a focus on downside risk mitigation amid industry-specific challenges.

View recap

Granite Construction Incorporated

GVA Q3 2025

Reported: 2025-11-08

Granite Construction Inc. reported robust third-quarter earnings, driven by significant acquisitions and strong demand across its Materials segment, indicating a positive outlook for sustained growth.

Key takeaways

Materials segment cash gross profit margin surged to 29% from 18% in FY 2022, fueled by strategic acquisitions and operational enhancements.
The recent acquisition of Cinderlite enhances Granite's aggregate reserves by approximately 100 million tons, further solidifying its position in Northern Nevada.
Overall aggregate production increased to 25 million tons, a substantial rise from 16 million tons in 2021, demonstrating effective scaling of operations.
Continued focus on M&A and capital project investments is expected to drive further revenue growth and improve profitability across the Materials business.
Strong public sector demand remains a key growth driver, with orders as of Q3 outpacing the previous year, positioning Granite well for sustained business momentum.

View recap

Hensoldt AG

HAG.DE Q3 2025

Reported: 2025-11-08

Hensoldt reports robust 9M 2025 results with order intake exceeding EUR 2 billion, driven by strong demand in the defense sector and a strategic boost from key contracts.

Key takeaways

Order intake reached over EUR 2 billion, up 9% year-over-year, marking a strong defense budget momentum.
Revenue grew to EUR 1.5 billion, with core revenue increasing by 14%, enhancing confidence in future growth.
Record order backlog of EUR 7.1 billion, supported by a book-to-bill ratio of 1.3x, providing excellent visibility into upcoming quarters.
Adjusted EBITDA rose to EUR 211 million, with a margin of 13.7%, bolstered by synergies from recent acquisitions.
Significant contracts in the pipeline, including a EUR 850 million sustainment contract for the P-8 Poseidon program and a new production site to increase capacity.

View recap

Hensoldt AG

HAGHY Q3 2025

Reported: 2025-11-08

Hensoldt's 9M 2025 results demonstrate robust order intake and revenue growth, highlighting strong demand from defense contracts, particularly in the Sensors and Optronics segments.

Key takeaways

Order intake surpassed EUR 2 billion, driven by Eurofighter and TRML-4D radar programs, resulting in a record backlog of EUR 7.1 billion.
Revenue rose to EUR 1.5 billion, with core revenue increasing 14% year-over-year, excluding declining passthrough revenue.
Adjusted EBITDA improved to EUR 211 million, benefiting from higher volumes and cost synergies from the ESG acquisition.
The company has raised its book-to-bill guidance, anticipating significant future orders, with substantial contracts in the pipeline including an EUR 850 million reconnaissance vehicle.
Hensoldt continues to expand production capacity, launching the Operations 2.0 initiative and investing EUR 80 million in a new production site for air defense radars.

View recap

HCI Group, Inc.

HCI Q3 2025

Reported: 2025-11-08

HCI Group reported robust third-quarter results, with EPS of $4.90 and a significant decrease in loss ratio to 22%, underscoring strong operational performance and an improving balance sheet.

Key takeaways

Pretax income surged to over $90 million, with a year-to-date increase of over 70% compared to last year.
Book value per share rose more than 50% year-to-date to $63, contributing to total shareholders' equity of $821 million.
Combined ratio improved to 64%, reflecting lower claim frequency and reduced operating expenses.
Successfully assumed over 47,000 policies from Citizens, adding approximately $175 million in in-force premium.
Exzeo's IPO solidified HCI's ownership value while the recent credit facility enhancements provide increased financial flexibility.

View recap

Hecla Mining Company

HL Q3 2025

Reported: 2025-11-08

Hecla Mining Company delivered exceptional Q3 2025 results, achieving record revenues of $410 million, a significant decrease in net leverage to 0.3x, and generating strong free cash flow from all producing assets.

Key takeaways

Record net income of $101 million and adjusted EBITDA of $196 million driven by strong silver and gold prices.
Significant balance sheet improvement with an 83% reduction in net leverage from 1.8x to 0.3x, alongside elimination of over $15 million in annual interest expenses.
Positive free cash flow from all four producing mines, totaling $90 million for the quarter, highlighting operational efficiency and robust cash generation.
Continued investment in strategic growth projects, including completion of surface cooling at Lucky Friday and expansion initiatives at Greens Creek.
Cost discipline maintained with all-in sustaining costs of $11.01 per silver ounce and silver margins at $31.57 per ounce.

View recap

Huntsman Corporation

HUN Q3 2025

Reported: 2025-11-08

Huntsman Corporation reported solid third-quarter results, delivering $200 million in operating cash flow despite ongoing economic challenges in the U.S., China, and Europe.

Key takeaways

Successfully achieved $200 million in operating cash for the quarter; year-to-date free cash flow exceeds $100 million.
On track with a $100 million cost reduction program, including the closure of 7 sites and restructuring of over 600 positions.
Cautiously managing dividend payouts amid prolonged market downturns, signaling a focus on cash preservation and balance sheet strength.
Directing efforts towards optimizing supply chains and exploring cost-effective sourcing options, particularly from the U.S. for European operations.
Forecast for Q4 includes anticipated seasonality and potential inventory destocking, especially in Europe.

View recap

illumin Holdings Inc.

ILLM.TO Q3 2025

Reported: 2025-11-08

Illumin's Q3 2025 results reflect a strategic pivot towards an integrated outcomes-based platform, driving a 5% year-over-year revenue increase to $38.2 million, bolstered by a substantial 103% growth in Exchange service revenue.

Key takeaways

Exchange service revenue surged to $20.5 million, now constituting 54% of total sales.
Self service revenue, excluding a significant client pause, increased 34% year-over-year, with the onboarding of 23 new high-spend clients.
Managed service revenue faced challenges but is being revitalized through an outcomes-based sales approach under new Chief Revenue Officer, Brian Garrigan.
Operational restructuring is underway to enhance profitability and cash flow, with a focus on leveraging technology and reducing costs.
Continued investments in AI-driven capabilities and product differentiation are critical for sustainable competitive advantages moving into 2026.

View recap

indie Semiconductor, Inc.

INDI Q3 2025

Reported: 2025-11-08

Indie's Q3 2025 results demonstrated strong revenue growth and strategic advancements, with total revenue reaching $53.7 million while expanding its market presence in adjacent sectors like quantum computing and robotics.

Key takeaways

Total revenue of $53.7 million aligns with guidance, showcasing solid quarter-over-quarter performance.
Strategic backlog increased to $7.4 billion, emphasizing a shift towards higher margin product offerings post divestment of Wuxi.
Successful design wins in advanced camera processing for leading self-driving and electric vehicle manufacturers, particularly in the robust Chinese market.
Notable milestones in radar technology with a Tier 1 partner launching a next-generation chipset, enhancing capabilities and performance metrics.
Broader adoption of the G2.0 wireless charging platform with production set to commence at Ford in Q1 2026.

View recap

Inseego Corp.

INSG Q3 2025

Reported: 2025-11-08

Inseego Corp. reported strong Q3 2025 results, with revenue of $45.9 million and adjusted EBITDA of $5.8 million, exceeding expectations for the second consecutive quarter and reflecting solid demand across its Fixed Wireless Access (FWA) and mobile products.

Key takeaways

FWA shipment volumes increased over 50% year-over-year, driven by strong demand and execution, particularly with T-Mobile.
Successfully secured a new Tier 1 U.S. carrier, bringing the total to three, enhancing market reach and potential revenue.
Launched the FX4200 broadband solution, integrating advanced performance and simplicity, aimed at increasing market opportunities and recurring revenue.
Released a major upgrade of Inseego Connect, transforming it into a central part of the enterprise offering with enhanced features for 5G network management.
Strengthened leadership team with experienced executives, bolstering capabilities for sustainable growth moving forward.

View recap

Kingstone Companies, Inc.

KINS Q3 2025

Reported: 2025-11-08

Kingstone Companies reported a record-setting third quarter with net income of $10.9 million and an impressive annualized return on equity of 43%, driven by strong premium growth and cost management.

Key takeaways

Net written premiums grew by 14%, primarily from a 13% average premium increase and enhanced retention rates.
The GAAP combined ratio improved to 72.7%, marking the eighth consecutive quarter of profitability.
Net investment income surged 52% to $2.5 million, bolstered by higher fixed income yields and robust cash flow.
Updated 2025 guidance reflects a raised forecast for EPS, net combined ratio, and ROE, with projected direct-written premium growth of 12% to 17%.
Kingstone's strategic focus on preferred risk products led to a 31% reduction in claim frequency for its Select homeowners portfolio compared to legacy offerings.

View recap

KKR & Co. Inc.

KKR Q3 2025

Reported: 2025-11-08

KKR reported a strong Q3 2025, achieving record fee-related earnings and total operating earnings, driven by robust capital raising and deployment across various asset classes.

Key takeaways

Fee-related earnings reached $1.15 per share, with total operating earnings at $1.55 per share, both records in the company's public history.
Capital raised in the quarter was $43 billion, marking the second-highest fundraising quarter ever for KKR, bolstered by strong inflows into credit and private equity segments.
Investment performance remained strong with $1 billion in monetization activity and $17 billion in embedded gains on the balance sheet.
The firm invested $26 billion in Q3, contributing to a cumulative $85 billion over the last 12 months, with a record dry powder of $126 billion available for future investments.

View recap

Koppers Holdings Inc.

KOP Q3 2025

Reported: 2025-11-08

Koppers reported a challenging third quarter with a 12% decline in sales year-over-year, primarily affected by market headwinds, although strategic cost control efforts led to improved adjusted EBITDA margins.

Key takeaways

Adjusted EBITDA for Q3 2025 came in at $70.9 million, down from $77.4 million in Q3 2024, reflecting effective cost management amidst declining revenues.
SG&A expenses were reduced by 14% year-to-date compared to the previous year, equating to over $19 million in savings.
Continued portfolio simplification with the divestiture of the Railroad Structures business, focusing on enhancing operational efficiency and reducing complexity.
Notable improvements in safety metrics, with recordable injuries down 23% and serious incidents down 72%.
Welcomed Laura Posadas to the Board, enhancing governance with her extensive experience in innovation and business strategy.

View recap

Klaviyo, Inc.

KVYO Q3 2025

Reported: 2025-11-08

Klaviyo delivered strong Q3 Fiscal 2025 results with revenue of $311 million, representing a 32% year-over-year increase and indicating robust growth strategies, particularly in the enterprise segment.

Key takeaways

Achieved record net adds in the $50,000-plus ARR customer cohort, underscoring strong demand.
Revenue grew 43% year-over-year in EMEA and APAC regions, highlighting successful international expansion.
Launched Agentic AI, enhancing marketing capabilities and customer engagement, leading to higher campaign performance metrics for clients.
Expanded capabilities for businesses to interact with consumers through multiple channels, boosting incremental sales and efficiency.
Serving over 183,000 customers globally, including over 6,000 enterprise and mid-market brands, which signals strong market penetration and brand recognition.

View recap

nLIGHT, Inc.

LASR Q3 2025

Reported: 2025-11-08

nLIGHT, Inc. delivered a strong Q3 2025 performance, achieving $67 million in revenue—19% growth year-over-year—primarily driven by record defense product sales. The company reported a record gross margin of 41% and exceeded adjusted EBITDA expectations.

Key takeaways

Record aerospace and defense revenue of $46 million, up 50% year-over-year, with defense product sales skyrocketing 71%.
Adjusted EBITDA surpassed expectations, exceeding $7 million as a result of improved gross margins and disciplined operational costs.
Significant progress on the $171 million HELSI-2 program and a new $50 million contract in missile guidance highlight strong growth prospects in directed energy and laser sensing sectors.
nLIGHT is strategically positioned to benefit from increased U.S. directed energy initiatives and international market expansion for defense applications.

View recap

Centrus Energy Corp.

LEU Q3 2025

Reported: 2025-11-08

Centrus Energy reported $74.9 million in revenue for Q3 2025, with a net income of $3.9 million, reflecting strong year-to-date performance and strategic developments ahead of growth opportunities.

Key takeaways

Year-to-date net income reached $60 million, significantly up from $19.5 million a year ago, signaling robust progress.
Successful closure of an oversubscribed convertible senior note transaction boosted unrestricted cash to over $1.6 billion, enhancing financial flexibility.
Secured waivers from the DOE for continued LEU imports, reducing operational risk for future transactions with U.S. customers.
Launched a $1 billion at-the-market fundraising program to support planned industrial expansion.
Engaged in strategic partnerships, including an agreement with KHNP and POSCO International to enhance enrichment capacity, underscoring growing market interest.

View recap

AEye Inc. Class A Common Stock

LIDR Q3 2025

Reported: 2025-11-08

AEye reported robust progress in Q3 2025, achieving increased customer contracts and securing additional funding for scalable production as its Apollo product gains traction in the market.

Key takeaways

Customer contracts doubled since Q2, reaching 12 signed agreements year-to-date, including a significant deal with a global defense contractor.
Active commercial pipeline tripled, with 2 dozen quotes in play, indicating strong demand and future revenue visibility.
Expansion of the manufacturing agreement with LITEON to support a new production line capable of 60,000 units annually, reflecting confidence in demand for Apollo.
Continued engagement with approximately two-thirds of major Western automotive OEMs, leveraging Apollo’s compact design for enhanced vehicle integration.
Strategic partnerships, including collaborations with Blue-Band and Black Sesame Technologies, expanding Apollo’s applications across defense, aviation, and automotive sectors.

View recap

Compania de Distribucion Integral Logista Holdings, S.A.

LOG.MC Q4 2025

Reported: 2025-11-08

Logista's fiscal year 2025 demonstrated steady economic sales growth in key markets, with profitability bolstered by favorable tobacco pricing changes, despite a decline in adjusted EBIT and net profit.

Key takeaways

Economic sales rose to EUR 1.8 billion, reflecting a 3% year-over-year increase, driven by strong performance in tobacco and pharma segments.
Profit on inventory reached EUR 45 million, supported by increased tobacco taxes and retail pricing across Iberia, Italy, and France.
Net profit declined 9% to EUR 281 million, attributed to lower financial income from a drop in average interest rates.
A final dividend of EUR 1.53 per share will be proposed, maintaining the previous year's distribution with a 99% payout ratio despite profit fluctuations.
Significant progress towards sustainability targets, including 85% of transport kilometers traveled using Euro 6 vehicles and 32% female representation in management.

View recap

Open Lending Corporation

LPRO Q3 2025

Reported: 2025-11-08

Open Lending reported mixed Q3 2025 results, showcasing a transition towards stable earnings, highlighted by the launch of the new ApexOne Auto platform aimed at the prime auto lending market.

Key takeaways

Introduced ApexOne Auto, expanding revenue potential with a subscription-based decisioning tool for prime auto borrowers, addressing a $500 million market opportunity.
Achieved three consecutive quarters of positive adjusted EBITDA, reflecting improved profitability and reduced volatility in core Lenders Protection platform.
Total certified loans decreased by 13% year-over-year to 23,880, driven by tighter lending standards and targeted rate adjustments in lower-margin segments.
Notable mix shift with 89.8% of loans facilitated through credit unions and banks, indicating a more focused approach to lending partnerships.
Continued enhancements in underwriting standards are expected to improve credit quality and support sustainable profitability going forward.

View recap

A.P. Moller - Maersk A/S

MAERSK-B.CO Q3 2025

Reported: 2025-11-08

A.P. Møller - Maersk delivered strong third-quarter results, with EBITDA of $2.7 billion and EBIT of $1.3 billion, driven by strong volume growth and cost control across all segments despite a challenging external environment.

Key takeaways

Logistics & Services recovered with a year-on-year EBIT margin increase to 5.5%, supported by improved asset utilization and productivity.
The Ocean segment achieved high reliability above 90%, with volumes rising 7% year-on-year, even amid softening freight rates.
Terminal revenues and profitability hit record levels, bolstered by the successful implementation of the Gemini cooperation and high utilization rates at terminals.
Full-year 2025 EBIT guidance has been narrowed to between $3 billion and $3.5 billion, reflecting sustained demand growth, particularly from China.

View recap

MarketAxess Holdings Inc.

MKTX Q3 2025

Reported: 2025-11-08

MarketAxess reported a slight year-over-year revenue increase to $209 million in Q3 2025, driven by a 10% growth outside of U.S. credit amid challenging market conditions.

Key takeaways

Block trading ADV increased by 10% in Q3, with October seeing a further 21% rise, showcasing strong demand in key markets.
Total portfolio trading ADV surged by 50% year-to-date, boosted by a 360 basis point market share increase in U.S. high yield.
New protocol launches, including closing auctions, aim to enhance liquidity and organization in fixed income trading.
International client volume has grown significantly, now representing 36% of global credit trading, up from 29% in 2020.
The dealer-initiated channel achieved a 34% increase in ADV year-to-date, driven by the successful rollout of the Mid-X solution.

View recap

Monster Beverage Corporation

MNST Q3 2025

Reported: 2025-11-08

Monster Beverage Corporation reported record quarterly net sales of $2.2 billion in Q3 2025, marking a 16.8% increase year-over-year, driven by strong performance across international markets and successful product innovation.

Key takeaways

Net income and operating income grew at a pace that outstripped net sales growth.
International sales represented 43% of total net sales, the highest in company history, with robust growth in all regions.
The growing portfolio includes innovations like the Monster Energy Lando Norris Zero Sugar product, tapping into popular sponsorships like Formula 1 and the Summer X Games.
Continued strategies to mitigate tariff impacts on aluminum and raw material imports, with expectations for modest ongoing costs.
The energy drink category remains vibrant with overall growth rates in the U.S. and internationally at 12.2% and 20%, respectively.

View recap

MP Materials Corp.

MP Q3 2025

Reported: 2025-11-08

MP Materials achieved record production and sales in Q3 2025, driven by strategic partnerships and a strong operational ramp-up, positioning the company for profitability in Q4 and beyond.

Key takeaways

NdPr oxide production increased 21% sequentially and 51% year-over-year to a record 721 metric tons.
Commenced a long-term purchase price agreement with the Department of War, enhancing earnings visibility for future growth.
Received the first $40 million prepayment from Apple to support magnet production from recycled materials, with total prepayments expected to reach $200 million.
On track to begin commercial-scale magnet production by year-end 2025, reflecting strong progress in the U.S. magnetics platform.

View recap

Motorsport Games Inc.

MSGM Q3 2025

Reported: 2025-11-08

Motorsport Games reported continued improvement in Q3 2025, achieving profitability for the second consecutive quarter, driven by strong user engagement and successful expansions of Le Mans Ultimate and RaceControl.

Key takeaways

Le Mans Ultimate transitioned successfully from early access to full release, resulting in record daily active users.
Introduction of incremental downloadable content (DLC) and user features like driver swaps bolsters player engagement and retention.
RaceControl subscription service achieved its highest performance quarter, processing nearly 100,000 deliveries.
Plans are in place to expand Le Mans Ultimate to console platforms, maintaining overall development momentum without jeopardizing current services.

View recap

Nektar Therapeutics

NKTR Q3 2025

Reported: 2025-11-08

Nektar Therapeutics reports robust advancements in clinical trials, particularly for rezpegaldesleukin (REZPEG), positioning itself for potential market leadership in atopic dermatitis and alopecia areata.

Key takeaways

Successfully advanced REZPEG into the Phase III development stage, targeting moderate to severe atopic dermatitis.
Strong preliminary results from the RESOLVE-AD study, showcasing REZPEG's differentiation from existing treatments, particularly for patients with comorbid asthma.
Planned presentations of 52-week maintenance data in Q1 and top-line results from alopecia areata studies are expected to further bolster the therapeutic profile.
Nektar aims to capture a significant portion of the $1 billion alopecia areata market with REZPEG as a potential first biologic therapy.
Upcoming FDA end-of-Phase II meeting anticipated to discuss Phase III plans for REZPEG in atopic dermatitis.

View recap

NewLake Capital Partners, Inc.

NLCP Q3 2025

Reported: 2025-11-08

NewLake Capital Partners reported third quarter 2025 results in line with expectations, driven by strong tenant performance despite ongoing challenges in the cannabis sector.

Key takeaways

AFFO increased over 2% year-over-year, with an AFFO payout ratio of 82%, within the target range.
All scheduled rents were collected except for two AYR properties, which are now being re-tenanted after regaining control.
Notable performances from tenants: Curaleaf reported over $100 million in cash flow yearto-date, and Cresco achieved positive cash flow and reduced debt.
The company remains cautiously optimistic about federal cannabis reform, emphasizing proactive risk management and potential diversification beyond cannabis.
Total revenue for Q3 reached $12.6 million, reflecting a 0.3% year-over-year increase amidst a challenging regulatory environment.

View recap

FiscalNote Holdings, Inc.

NOTE Q3 2025

Reported: 2025-11-08

FiscalNote Holdings delivered stable financial performance in Q3 2025, with revenue of $22.4 million and adjusted EBITDA exceeding expectations, signaling strong operational efficiency and growth momentum.

Key takeaways

Revenue of $22.4 million met guidance, while adjusted EBITDA reached $2.2 million, achieving a solid 10% margin for the fifth consecutive quarter.
Operating expenses reduced by approximately 8% pro forma, reflecting ongoing cost discipline and improved operational efficiency.
Annual recurring revenue (ARR) stabilized, with notable increases in enterprise win rates and contract values, indicating enhanced sales performance and revenue visibility.
Significant product innovation with over 35 major enhancements to the PolicyNote platform this year, contributing to user engagement and retention.
Balance sheet extended with four-year maturity enhancements, strengthening financial flexibility for future growth initiatives.

View recap

NerdWallet Inc. Class A Common Stock

NRDS Q3 2025

Reported: 2025-11-08

NerdWallet demonstrated strong financial performance in Q3 2025, surpassing revenue and profitability expectations driven by significant growth in banking and personal loans while maintaining focus on operational efficiency.

Key takeaways

Total revenue increased by 12% year-over-year to $215 million, exceeding guidance of $189 million to $197 million.
Non-GAAP operating income reached $41 million, well above the target range of $23 million to $27 million, supported by improved efficiency and conservative expense management.
Banking revenue surged 96% year-over-year and personal loans grew 91%, offsetting declines in SMB products and credit cards due to organic search challenges.
The company executed $19 million in share repurchases, reinforcing confidence in its long-term prospects.
For Q4, revenue is anticipated to be between $207 million and $215 million, amid continued high growth in banking and personal loans.

View recap

Nu Skin Enterprises, Inc.

NUS Q3 2025

Reported: 2025-11-08

Nu Skin Enterprises reported Q3 2025 revenue of $364 million, aligning with guidance, and delivered an EPS of $0.34, reflecting robust performance amid macro challenges. The company is poised for growth with the upcoming introduction of its Prysm iO wellness platform and entry into the Indian market.

Key takeaways

Revenue declined year-over-year but remained within guidance; North America faced transformation challenges while Latin America grew 53%.
Launch of Prysm iO, an intelligent wellness platform, scheduled for limited previews in Q4, aiming to enhance customer engagement and lifetime value.
Expansion into India is a strategic focus, targeting a growing middle class with a tailored product portfolio and compensation plan to boost market presence.
Sequential growth noted in Europe, Africa, South Korea, and Southeast Asia, signaling recovery in key international markets.
Nu Skin's significant investment in intelligent wellness reflective of market trends, with a potential market for nutritional supplements anticipated to surpass $700 billion by 2030.

View recap

NexGen Energy Ltd.

NXE.TO Q3 2025

Reported: 2025-11-08

NexGen Energy's Q3 2025 performance showcases significant advancements driven by surging uranium demand and strategic execution ahead of the Rook I project commissioning hearings.

Key takeaways

Uranium spot prices increased 16% to USD 83.25 per pound, reflecting heightened market liquidity and supply disruptions.
U.S. government investments and recent partnerships bolster nuclear energy initiatives, reinforcing NexGen's strategic positioning.
Rising demand projections indicate a potential uranium market deficit, necessitating higher prices and new supply sources, including Rook I.
NexGen's advanced development efforts align well with the uranium market's expected upward price trajectory and growing global nuclear energy reliance.

View recap

one

ONEX.TO Q3 2025

Reported: 2025-11-08

Onex demonstrates robust strategic advancements in Q3 2025, highlighted by the transformative acquisition of Convex and a strategic partnership with AIG, poised to enhance shareholder value significantly.

Key takeaways

The acquisition of Convex, growing gross written premiums by 22% annually, positions Onex for strong future returns with minimal risk.
AIG's $2 billion commitment to Onex' funds is expected to generate $15 million to $20 million in incremental fee-related earnings, bolstering financial performance.
Onex anticipates Convex will constitute 42% of its balance sheet post-acquisition, with strategies focused on deploying remaining capital towards internal and third-party investments for greater growth.
Continued positive momentum in structured credit, with credit performance exceeding expectations and contributing to advancing fee-related earnings for the year.

View recap

Orion Office REIT Inc.

ONL Q3 2025

Reported: 2025-11-08

Orion Properties reported significant leasing momentum and strategic asset sales in Q3 2025, enhancing portfolio quality and outlook for the coming quarters.

Key takeaways

Achieved 303,000 square feet of leasing with a weighted average lease term of over 10 years, driving portfolio stability.
Completed sales of 761,000 square feet and have additional agreements for over 500,000 square feet, generating over $110 million in gross proceeds.
Portfolio occupancy improved to 72.8%, with expectations of continued increases as leases are signed and properties are sold.
Positive rent spreads observed, with over 2% for renewals, indicating strong demand and tenant confidence.
Focus remains on transitioning from traditional office properties to dedicated use assets (DUAs) for more durable cash flows.

View recap

Onto Innovation Inc.

ONTO Q3 2025

Reported: 2025-11-08

Onto Innovation's Q3 2025 results surpassed guidance, driven by strong demand for advanced packaging technologies and strategic product developments, positioning the company for significant growth in 2026.

Key takeaways

Q3 revenue reached $218.2 million, slightly above the midpoint of guidance, with gross margins at 54%.
Successful qualification of 3Di technology at two key customers positions Onto for volume orders in the advanced packaging sector.
Anticipating a robust Q4 with nearly double revenue from 2.5D packaging customers, contributing to a projected 18% revenue growth.
Advanced nodes revenue for the year expected to double to approximately $300 million, indicating strong market traction.
Ongoing integration of Semilab's product lines expected to enhance revenue and earnings starting 2026.

View recap

Opendoor Technologies Inc.

OPEN Q3 2025

Reported: 2025-11-08

Opendoor demonstrated a significant turnaround in Q3 with a strategic shift towards rapid home acquisitions and operational excellence under new leadership, signaling a refocused business model aimed at leveraging technology to streamline home transactions.

Key takeaways

Home acquisitions nearly doubled from 120 to 230 per week, showcasing improved operational efficiency.
Transitioning from asset management to a software-focused model, emphasizing the integration of AI in pricing and operations.
Launch of Opendoor Checkout and expansion of related services including mortgage and insurance, aiming to enhance consumer value.
Commitment to strict operational rigor and data-driven inspection processes to ensure asset quality and transaction speed.
Rejection of risk-averse strategies in favor of aggressive home buying and sales practices to capitalize on market opportunities.

View recap

Organogenesis Holdings Inc.

ORGO Q3 2025

Reported: 2025-11-08

Organogenesis Holdings reported strong third quarter results for 2025, driven by a 31% increase in Advanced Wound Care product sales and strategic advancements in Medicare payment reforms, positioning the company favorably for future growth.

Key takeaways

Q3 revenues exceeded guidance, with Advanced Wound Care sales up 31% year-over-year and Surgical & Sports Medicine sales climbing 25%.
The finalization of Medicare physician fee schedules marks a significant development, offering expanded access and potential for higher reimbursement for PMA products.
Progress on the ReNu program includes favorable clinical results, FDA RMAT designation, and an upcoming meeting scheduled for December to discuss the BLA submission.
The company maintained its competitive edge through strong brand equity and established customer relationships in the evolving skin substitute market.
Organogenesis is well-positioned to leverage changes in Medicare policy and drive innovation in regenerative medicine.

View recap

Penn National Gaming, Inc.

PENN Q3 2025

Reported: 2025-11-08

Penn Entertainment's Q3 2025 results reflect strategic recalibration in its interactive business, including the early termination of its ESPN marketing agreement, while reporting record gains in its iCasino segment.

Key takeaways

Early termination of the ESPN marketing agreement to refocus on core digital assets, including the Score Bet brand, effective December 1.
Record quarterly gaming revenue for the North America iCasino business, up nearly 40% year-over-year, driven by strong cross-sell initiatives.
79% surge in monthly active users for iCasino services during Q3, bolstered by the successful standalone app and integration with sports betting.
Strong performance trends across core regional casinos, notably in the West segment, with solid visitation and spending metrics.
Ongoing development projects are on schedule, with new openings anticipated in late 2023 and throughout 2026.

View recap

Progyny, Inc.

PGNY Q3 2025

Reported: 2025-11-08

Progyny reported strong Q3 results, exceeding revenue and profitability guidance while significantly expanding its client base, resulting in a quarterly revenue guidance increase of over $70 million.

Key takeaways

Q3 revenue and adjusted EBITDA surpassed expectations, leading to raised full-year guidance for the third consecutive quarter.
Acquired over 80 new logos and 900,000 covered lives during the recent selling season, demonstrating strong demand for family-building and women's health solutions.
Achieved nearly 100% renewal rate of existing clients and expanded benefits for nearly 30% of clients for 2026, validating market leadership.
New services in pregnancy postpartum and menopause have gained notable traction, adding access for 2.7 million members next year.
White House initiative to expand access to fertility care represents a positive outlook for Progyny, especially in the small and midsized employer market.

View recap

Palomar Holdings, Inc.

PLMR Q3 2025

Reported: 2025-11-08

Palomar Holdings delivered an exceptional third quarter in 2025, achieving record gross written premiums and adjusted net income, marking the 12th consecutive quarter of earnings beats.

Key takeaways

Gross written premiums increased by 44%, alongside a 70% rise in adjusted net income year-over-year.
Adjusted combined ratio stood at 75%, with a robust adjusted return on equity of 26%, reflecting strong underwriting discipline.
Recent acquisition of Gray Casualty and Surety Company is expected to significantly enhance Palomar's surety platform and market presence.
All product lines showed strong double-digit growth, contributing to overall solid performance despite prevailing market challenges.
Continued expansion in specialty markets and strategic partnerships is poised to sustain long-term growth and profitability.

View recap

Pembina Pipeline Corporation

PPL.TO Q3 2025

Reported: 2025-11-08

Pembina Pipeline Corporation reported a strong Q3 2025 with adjusted EBITDA of $1.034 billion, maintaining guidance for robust annual performance and enhancing future growth prospects through strategic partnerships and capital projects.

Key takeaways

Adjusted EBITDA for Q3 reached $1.034 billion, reaffirming full-year guidance narrowed to $4.25 billion - $4.35 billion.
Secured a 20-year agreement with PETRONAS for 1 million tonnes of liquefaction capacity, bolstering its LNG export strategy.
Progressed development of the Greenlight Electricity Center, with a 907-megawatt power grid allocation secured for future customer infrastructure.
Completed substantial recontracting in the pipeline business, enhancing long-term revenue visibility with 80% of renewed volumes under 10-year agreements.
Capital projects nearing completion are optimized to be on time and under budget, including $850 million in projects expected to service in early 2026.

View recap

Proximus PLC

PROX.BR Q3 2025

Reported: 2025-11-08

Proximus reported steady performance in Q3 2025, with domestic EBITDA growth of 1.8%, and strategic divestitures progressing toward its EUR 600 million asset sales target, while facing challenges in its Global segment.

Key takeaways

Domestic EBITDA rose to EUR 475 million, driven by a favorable revenue mix and stable costs.
Mobile postpaid and internet subscribers increased by 45,000 and 12,000, respectively, underlining strong operational performance.
Proximus revised its 2025 EBITDA outlook for the Global segment to a decline of approximately 10% due to integration and legacy business challenges.
Continued expansion of fiber coverage to 47% of Belgian homes, with nearly 684,000 active fiber customers.
Interim dividend of EUR 0.30 per share confirmed, payable on December 5, reflecting confidence in cash flow despite obstacles.

View recap

Q2 Holdings, Inc.

QTWO Q2 2025

Reported: 2025-11-08

Q2 Holdings reported exceptional third-quarter results, with revenue and adjusted EBITDA surpassing guidance, driven by a record number of bookings across Tier 1 and enterprise segments.

Key takeaways

Revenue reached $202 million, reflecting a 15% year-over-year growth, while adjusted EBITDA stood at $49 million (24.2% margin).
Achieved record bookings in Q3, including 7 new Tier 1 and enterprise deals.
Secured major wins in digital banking and fraud solutions, including the largest fraud deal in company history.
Hosted successful Dev Days 2025, highlighting advancements in AI capabilities and integration strategies.
Maintained a solid pipeline and raised guidance expectations for the upcoming quarter.

View recap

Ready Capital Corporation

RC Q3 2025

Reported: 2025-11-08

Ready Capital reported a challenging third quarter 2025, marked by a GAAP loss, as the company focused on balance sheet repositioning and improvement in its Small Business Lending operations amidst heightened delinquencies and maturing debt.

Key takeaways

Successfully repositioned balance sheet; netted $109 million from the sale of low-yielding loans, contributing $0.02 per share in the quarter.
Increased delinquencies to 5.9% as new core net delinquencies amounted to $40 million; strategic emphasis placed on asset liquidations.
Small Business Lending operations generated $11 million in net income, with continued growth opportunities despite current market pressures.
The company is prioritizing the management of $650 million in debt maturing in 2026, with $830 million in unencumbered assets to address obligations.
Evaluating dividend levels in December based on progress and liquidity management for upcoming maturities.

View recap

Royal Gold, Inc.

RGLD Q3 2025

Reported: 2025-11-08

Royal Gold delivered a record-breaking third quarter for 2025, with revenue reaching $252 million, driven by a strong gold market and successful portfolio expansions.

Key takeaways

Adjusted net income for the quarter was a record $136 million, or $2.06 per share, significantly benefiting from high gold and silver prices.
Revenue from the royalty segment rose 41% year-over-year, supported by strong performance from major assets including Peñasquito and Cortez.
The successful acquisition of Sandstorm Gold and Horizon Copper enhances Royal Gold's portfolio with additional quality producing and development assets.
Mount Milligan's mine life extension to 2045 represents a significant value increase for Royal Gold's largest asset, while Cortez's Fourmile project promises potential future production growth.
The dividend of $0.45 per share underlines the company's commitment to shareholder returns amid robust cash flow generation.

View recap

Runway Growth Finance Corp.

RWAY Q3 2025

Reported: 2025-11-08

Runway Growth Finance reported solid third-quarter performance with total investment income of $36.7 million, emphasizing strategic growth through a definitive merger agreement to acquire SWK Holdings, which will enhance portfolio diversification and earnings power.

Key takeaways

Total investment income of $36.7 million and net investment income of $15.7 million for Q3 2025.
Completed 11 investments totaling $128.3 million, reinforcing the focus on technology, healthcare, and select consumer sectors.
Notable merger agreement to acquire SWK Holdings, expected to scale the portfolio by $242 million, significantly increasing exposure in healthcare and life sciences to approximately 31%.
Strategy includes enhancing portfolio risk profile through diversification and smaller investment sizes, as well as expanding financing solutions.
Ongoing commitment to explore inorganic growth opportunities within the BC Partners Credit ecosystem, positioning Runway for further competitive advantage.

View recap

The Beauty Health Company Class A Common Stock

SKIN Q3 2025

Reported: 2025-11-08

The Beauty Health Company reported Q3 2025 net sales of $70.7 million, a 10.3% decrease year-over-year, attributed primarily to reduced device sales and ongoing transitions in the China market.

Key takeaways

Device revenues fell 24.6% to $20.8 million, reflecting global sales pressure and a shift to a distributor model in China.
Consumables represented 71% of total sales, up from 65% a year prior, with stability seen once China’s impact is excluded.
Adjusted EBITDA rose 11% year-over-year to $8.9 million, highlighting effective cost control despite revenue declines.
Inventory levels reached their lowest in three years at under $60 million thanks to improved demand planning.
The company raised its adjusted EBITDA guidance for the remainder of 2025, indicating positive momentum entering 2026.

View recap

SharkNinja, Inc.

SN Q3 2025

Reported: 2025-11-08

SharkNinja reported strong third-quarter results, with net sales growing over 14% year-over-year and adjusted EBITDA increasing nearly 21%, demonstrating resilience in a challenging market environment.

Key takeaways

Achieved double-digit net sales growth for the tenth consecutive quarter, driven entirely by organic growth.
Expanded adjusted gross margins to surpass 50%, marking a year-over-year increase of over 90 basis points.
Notable acceleration in international sales growth, reaching almost 26% year-over-year in Q3.
Strengthened relationships with retail partners and significant traction in direct-to-consumer channels, including a major website redesign.
Welcomed celebrity ambassadors Kevin Hart and Tom Brady to enhance brand engagement and marketing initiatives.

View recap

Solventum Corporation

SOLV Q3 2025

Reported: 2025-11-08

Solventum delivered strong Q3 results, showcasing robust volume growth and operational effectiveness, prompting an increase in both sales growth and EPS guidance for the fiscal year.

Key takeaways

Positive volume growth contributed to both top and bottom line performance, driving an upward revision in annual guidance.
Successful restructuring and leadership upgrades yielded significant improvements in commercial execution and accountability.
Expansion of the product pipeline with nearly doubled vitality index enhances innovation and future revenue potential.
Initiative to optimize the asset portfolio and focus on strategic M&A opportunities aims to boost operational efficiency and reduce debt.
Strong growth in Dental Solutions and Advanced Wound Care underscores solid momentum across core business segments.

View recap

StoneCo Ltd.

STNE Q3 2025

Reported: 2025-11-08

StoneCo demonstrated resilient performance in Q3 2025, achieving a 15.2% year-to-date growth in adjusted gross profit and a 37% increase in adjusted EPS amidst a challenging macro environment.

Key takeaways

Adjusted net income rose 18% year-over-year, with a consolidated ROE improving to 24%.
Total revenue reached BRL 3.6 billion, driven by solid execution in core business despite lower floating revenues.
Active client base grew 17% to 4.7 million, reflecting strong engagement in the MSMB segment.
Client deposits increased by 32% year-over-year, indicating higher adoption of banking solutions.
The credit portfolio grew 27% sequentially, maintaining strong asset quality with NPLs over 90 days at 5.03%.

View recap

TaskUs Inc. Class A Common Stock

TASK Q3 2025

Reported: 2025-11-08

TaskUs reported a record third quarter with $298.7 million in revenue, achieving a 17% year-over-year growth rate despite broader industry challenges. The strong financial results underscore the company's commitment to integrating AI into its service offerings.

Key takeaways

Revenue reached $298.7 million, marking the highest quarterly revenue in the company's history.
Adjusted EBITDA was $63.5 million, reflecting a margin of 21.2%.
Adjusted earnings per share reported at $0.42, up 14% year-over-year.
The company terminated its proposed take-private transaction after failing to gain shareholder approval, signaling strong valuation expectations from investors.
Future investments will focus on combining AI technology with human talent to enhance service delivery and transform the business model.

View recap

Turtle Beach Corporation

TBCH Q3 2025

Reported: 2025-11-08

Turtle Beach Corporation reported revenues of $80.5 million for Q3 2025, demonstrating solid operational execution amid market challenges, with improved gross margins and a robust focus on profitability.

Key takeaways

Revenue reached $80.5 million, supported by a 120 basis point year-over-year improvement in gross margins, now exceeding 37%.
Successful refinancing of the term loan reduced interest rates by over 450 basis points, enhancing financial flexibility and lowering capital costs.
$10 million in share repurchases was completed during the quarter, reinforcing the company’s commitment to returning capital to shareholders.
Launched over 40 new products since Q2, positioning Turtle Beach for strong momentum in the upcoming holiday season.
The company solidified its status as a gaming accessories leader through strategic partnerships with all three major console platforms.

View recap

Tecnicas Reunidas, S.A.

TRE.MC Q3 2025

Reported: 2025-11-08

Técnicas Reunidas reports strong performance in the first nine months of 2025, driven by robust growth in engineering services and ambitious targets in renewable energy sectors.

Key takeaways

Engineering services revenue is projected at €230 million for 2025, with a target of €500 million by 2028.
The company aims for yearly revenues exceeding €1 billion in the Power business by 2028, bolstered by a strong backlog and commercial pipeline.
Strategic alliances, particularly in North America with Zachry, position the company well in LNG and decarbonization projects.
A current project pipeline of €86 billion reflects significant growth opportunities across all regions, with North America capturing 33% of this total.
The unique partnership with Sinopec for the Yanbu Green Hydrogen cluster highlights the company’s commitment to leadership in green energy initiatives.

View recap

TripAdvisor, Inc.

TRIP Q3 2025

Reported: 2025-11-08

Tripadvisor reported solid third-quarter results with a 4% revenue increase to $553 million and adjusted EBITDA of $123 million, driven by substantial growth in its Experiences segment. The company is implementing key changes to streamline operations and enhance profitability.

Key takeaways

Consolidated revenue rose 4% year-over-year, reflecting strong performance in high-growth segments.
Adjusted EBITDA margins improved to 22%, exceeding expectations, driven by operational efficiencies and strategic focus on Experiences.
The company aims to achieve $85 million in annualized gross cost savings while prioritizing growth in the Experiences marketplace, which now represents nearly 60% of total revenue.
Tripadvisor and Viator will unify operations to capture broader market opportunities in Experiences, leveraging proprietary data and brand trust for competitive advantage.

View recap

TORM plc

TRMD Q3 2025

Reported: 2025-11-08

TORM's Q3 2025 results reflect strong performance amid a stable market, with a net profit of USD 78 million and a dividend declaration of USD 0.62 per share, driven by firm freight rates.

Key takeaways

Total TCE earnings reached USD 236 million, surpassing previous quarter levels due to improved freight rates.
Acquired five vessels, enhancing fleet modernization and supporting strategic optimization efforts.
Increased guidance midpoint for 2025, indicating robust visibility on future earnings with limited uncovered days remaining.
Market dynamics show continued demand growth amidst refinery closures and geopolitical challenges, reinforcing operational resilience.
OPEC's output changes and sanctions on Russian crude are anticipated to further boost product tanker demand.

View recap

Trupanion, Inc.

TRUP Q3 2025

Reported: 2025-11-08

Trupanion reported strong third-quarter 2025 results, marked by a 45% year-over-year increase in net pet additions and record subscription adjusted operating income of $39 million, reflecting successful retention strategies and robust revenue growth.

Key takeaways

Subscription revenue increased 15% year-over-year to $252.7 million, contributing to a total revenue growth of 12% to $366.9 million.
Net pet additions reached 16,000 in the quarter, marking the highest growth in seven quarters, with total subscription pets surpassing 1.08 million.
Adjusted operating margin for subscription business expanded to a record 15.5%, driven by improved efficiencies in fixed and variable expenses.
Average monthly retention improved slightly to 98.33%, underscoring strong member loyalty amidst a challenging veterinary care landscape.
Trupanion continues to invest aggressively in brand visibility and customer support initiatives to strengthen its market position.

View recap

Upland Software, Inc.

UPLD Q3 2025

Reported: 2025-11-08

Upland Software exceeded revenue and adjusted EBITDA guidance in Q3 2025, backed by strong organic growth and new customer acquisitions, while achieving significant improvements in debt management and liquidity.

Key takeaways

Q3 revenue outperformed guidance midpoint, with adjusted EBITDA of $16 million and a margin of 32%.
Core organic growth rate reached 3%, supported by the addition of 97 new customers, including 14 major wins.
Successfully refinanced debt, extending maturity to July 2031 and reducing net debt leverage to 3.8x.
Positive product developments included new AI features and significant contracts with notable Fortune 100 and global pharmaceutical companies.
Free cash flow generation of $6.7 million positions the company for continued balance sheet strength and future deleveraging.

View recap

Marriott Vacations Worldwide Corporation

VAC Q3 2025

Reported: 2025-11-08

Marriott Vacations Worldwide reported a 4% decline in contract sales year-over-year for Q3 2025, driven by weaker performance in key markets. Despite this setback, the company is implementing strategic changes aimed at driving future growth and optimizing its operations.

Key takeaways

Adjusted sales and marketing strategies aim to align short-term actions with long-term growth objectives.
New initiatives, including FICO scoring for marketing and reshaping owner experiences, are expected to enhance owner satisfaction and improve sales metrics.
Total adjusted EBITDA decreased by 15% year-over-year to $170 million, reflecting rising costs and lower sales volumes, though recurring revenue streams showed resilience.
The company plans to repay its 0% convertible debt with $575 million of newly issued senior notes, maintaining a strong liquidity position of $1.4 billion.
Full-year guidance now anticipates a 2-3% decline in contract sales, with stable expectations for management and financing profit.

View recap

Veritone, Inc.

VERI Q3 2025

Reported: 2025-11-08

Veritone Inc. showcased robust performance in Q3 2025, with a 32% increase in overall revenue and a significant milestone in debt reduction, positioning the company for sustained growth in the booming AI market.

Key takeaways

Total revenue exceeded $29 million, marking a 32% year-over-year growth driven by strong demand for aiWARE solutions.
Software Products & Services revenue surged 55%, with a remarkable 200% increase when excluding Veritone Hire.
Successfully retired all term debt and repurchased approximately 50% of outstanding convertible debt, reducing annual debt service burden by over 94%.
Launched the Veritone Data Refinery (VDR), setting the stage for innovative monetization initiatives beginning in Q1 2026.
Positioned as a leader in the AI-driven data economy, with projections indicating a potential $13.5 trillion global tokenized asset market by 2030.

View recap

Vitalhub Corp.

VHI.TO Q3 2025

Reported: 2025-11-08

VitalHub achieved a robust performance in Q3 2025, with total revenue soaring 94% year-over-year to $32 million, driven by strong organic growth and strategic acquisitions.

Key takeaways

Annual recurring revenue (ARR) reached $93.7 million, with a 15% organic growth rate year-over-year.
Gross margin maintained at 81%, and adjusted EBITDA grew to $7.2 million, representing 22% of revenue.
The Virtual Care segment contributed $2.5 million in its first full quarter, enhancing the overall revenue mix.
Significant cash position of $123.8 million with no debt, positioning the company for future growth and acquisitions.
Integration from recent acquisitions is progressing well, with expected synergies in product offerings and services contributing to future revenue streams.

View recap

Viemed Healthcare, Inc.

VMD Q3 2025

Reported: 2025-11-08

Viemed Healthcare delivered a robust third quarter in 2025, marked by significant growth across its diversified service lines and successful integration of the Lehan's Medical Equipment acquisition.

Key takeaways

Ventilation revenue achieved double-digit growth year-over-year, reflecting sustained demand and strategic positioning.
New sleep patient starts surged 96% year-over-year, with resupply population growth surpassing the PAP therapy rental base for the first time.
Integration of Lehan's expanded Viemed's employee base to 1,386 and facilitated entry into new markets and service offerings, including maternity health.
The Healthcare Staffing division showed resilience, contributing to operational synergies and continued growth.
Strategic execution positions Viemed for sustainable growth, enhancing its reputation as a trusted leader in home-based healthcare.

View recap

Vistra Corp.

VST Q3 2025

Reported: 2025-11-08

Vistra's robust third quarter 2025 results highlight significant advancements in operational execution and growth strategies, including acquisitions and new power agreements, positioning the company for sustainable future profitability.

Key takeaways

Adjusted EBITDA guidance for 2025 narrowed to $5.7 billion to $5.9 billion, with adjusted free cash flow before growth expected at $3.3 billion to $3.5 billion.
Introduced 2026 adjusted EBITDA guidance of $6.8 billion to $7.6 billion, driven by strong performance from recently acquired assets.
Secured a landmark 20-year power purchase agreement at Comanche Peak, ensuring operational stability through at least the mid-2050s.
Maintained a robust commercial performance with a generation fleet availability of approximately 93% and a nuclear capacity factor of 95%.
Continued strong growth in retail customer count, credited to enhanced service and brand portfolio in the Texas market.

View recap

The Wendy's Company

WEN Q3 2025

Reported: 2025-11-08

Wendy's third quarter results were broadly in line with expectations, driven by strong international sales growth and progress on the U.S. turnaround initiative, Project Fresh.

Key takeaways

International net unit growth projected to exceed 9% in 2025, fueled by strong same-restaurant sales and new openings.
U.S. company-operated restaurants significantly outperformed the system, achieving a 400 basis points lead in same-restaurant sales in Q3.
Project Fresh focuses on brand revitalization and operational excellence to increase guest frequency and drive average unit volumes (AUVs).
Investments in customer training and technology are enhancing the customer experience and improving metrics such as satisfaction scores and order accuracy.
Positive feedback from franchisees on Project Fresh reflects confidence in the brand's direction and strategy.

View recap

Willdan Group, Inc.

WLDN Q3 2025

Reported: 2025-11-08

Willdan Group's Q3 2025 results demonstrate robust growth with net revenues rising 26% year-over-year, driven by a strong organic growth rate and continued margin expansion.

Key takeaways

Achieved 20% organic growth, marking the fourth consecutive year of double-digit increases.
Utility business growth remains strong, constituting 41% of revenue, supported by long-term contracts and a healthy funding landscape.
Significant demand in engineering and consulting, particularly driven by data center projects; recent APG acquisition is performing well with expected 50% growth in 2026.
Total backlog of projects continues to strengthen, with notable contracts including a $97 million project for Alameda County.
Company raised full-year financial targets based on positive performance outlook and sustained demand across segments.

View recap

WW International, Inc.

WW Q3 2025

Reported: 2025-11-08

WeightWatchers demonstrated strong resilience in Q3 2025, leveraging its integration with GLP-1 medications to enhance member outcomes, positioning itself for renewed growth in the weight management sector.

Key takeaways

WeightWatchers Clinic significantly improved weight loss outcomes for members using GLP-1 medications, achieving a 19% to 23% average weight loss over three years.
98% of members prescribed weight management medication experienced more than 10% weight loss within 12 months.
The company is modernizing its digital platform to enhance member experience and engagement, with a focus on AI-driven personalized solutions.
A successful financial reorganization has strengthened the balance sheet, allowing for increased investments in growth and innovation.
The demand for GLP-1 medications continues to rise, with over 12% of U.S. adults currently utilizing these treatments, highlighting a significant market opportunity.

View recap

Xeris Pharmaceuticals, Inc.

XERS Q3 2025

Reported: 2025-11-08

Xeris Biopharma reported a record-setting Q3 2025 with total product revenue surpassing $74 million, reflecting a 40% year-over-year increase, driven primarily by exceptional growth in its flagship product, RECORLEV.

Key takeaways

RECORLEV revenue exceeded $37 million, representing a 109% year-over-year growth, supported by a 108% increase in the average number of patients on therapy.
Total revenue guidance for 2025 has been revised upward to $285-290 million, marking a projected 42% increase at the midpoint.
Gvoke and KEVEYIS achieved revenues of $25.2 million and $11.9 million, respectively, highlighting steady growth and an expanding patient base.
The company generated positive cash flow and net income for the first time, showcasing financial scalability and operational strength.
Strategic expansion initiative underway, nearly doubling sales and patient support teams, aiming to enhance reach and capitalize on market opportunities.

View recap

YETI Holdings, Inc.

YETI Q3 2025

Reported: 2025-11-08

YETI Holdings reported strong third-quarter results, driven by robust double-digit growth in the Coolers & Equipment category, and notable international expansion, while navigating challenges in U.S. e-commerce and wholesale sell-in.

Key takeaways

Double-digit growth in Coolers & Equipment, particularly in international markets, although U.S. e-commerce performance was soft.
Over 30 new product launches planned for 2025, enhancing the brand's innovative portfolio across Drinkware and Coolers.
Strong consumer demand for new products like the Silo Jug and upcoming YETI Shaker Bottle, targeting a $2.5 billion market segment in sports and wellness.
Ongoing strategic trade-offs to advance supply chain diversification amid pressures in U.S. wholesale inventory.

View recap

ZipRecruiter, Inc.

ZIP Q3 2025

Reported: 2025-11-08

ZipRecruiter demonstrated resilience in a challenging labor market during Q3 2025, reporting sequential revenue growth and significant advancements in performance-based revenue, marking its first year-over-year growth since Q3 2022.

Key takeaways

Revenue reached $115 million, exceeding guidance with a 2% sequential increase, although still down 2% year-over-year.
Paid employers increased to 67,000, achieving year-over-year growth for the first time since Q1 2022.
Performance-based revenue grew by 12% quarter-over-quarter, the highest rate in three years, driven by stronger enterprise customer adoption.
Strategic investments in AI and upgraded products are enhancing job seeker engagement, with a 140% increase in site visits from generative AI tools.
ZipIntro adoption surged, with an 80% increase in interviews scheduled for enterprise customers, highlighting efficient hiring solutions.

View recap

Earnings Recaps

Ares Commercial Real Estate Corporation

American Healthcare REIT, Inc.

ALX Oncology Holdings Inc.

A.P. Moller - Maersk A/S

Amylyx Pharmaceuticals Inc. Common Stock

Amadeus IT Group, S.A.

Arlo Technologies, Inc.

AdvanSix Inc.

AerSale Corporation

Avino Silver & Gold Mines Ltd.

Avino Silver & Gold Mines Ltd.

American States Water Company

AstraZeneca PLC

AstraZeneca PLC

Bridger Aerospace Group Holdings, Inc. Common Stock

Brookfield Asset Management Ltd.

Barings BDC, Inc.

Franklin Resources, Inc.

Blend Labs, Inc.

Compania Cervecerias Unidas S.A.

Constellation Energy Corporation

Cerus Corporation

IES Holdings, Inc.

Coherus BioSciences, Inc.

Curis, Inc.

Claritev Corporation

CytomX Therapeutics, Inc.

CareTrust REIT, Inc.

Curaleaf Holdings, Inc.

Docebo Inc.

Datadog, Inc.

Ginkgo Bioworks Holdings Inc. Class A Common Stock

Direct Digital Holdings Inc. Class A Common Stock

DiamondRock Hospitality Company

Duke Energy Corporation

DoubleVerify Holdings, Inc.

DXP Enterprises, Inc.

Eventbrite, Inc.

Ellington Financial Inc.

Emera Incorporated

EverCommerce Inc. Common Stock

Fomento de Construcciones y Contratas, S.A.

Fidus Investment Corporation

Fulgent Genetics, Inc.

FS KKR Capital Corp.

GigaCloud Technology Inc Class A Ordinary Shares

Globus Medical, Inc.

GoPro, Inc.

Grindr Inc. Common Stock

GrowGeneration Corp.

Goldman Sachs BDC, Inc.

Granite Construction Incorporated

Hensoldt AG

Hensoldt AG

HCI Group, Inc.

Hecla Mining Company

Huntsman Corporation

illumin Holdings Inc.

indie Semiconductor, Inc.

Inseego Corp.

Kingstone Companies, Inc.

KKR & Co. Inc.

Koppers Holdings Inc.

Klaviyo, Inc.

nLIGHT, Inc.

Centrus Energy Corp.

AEye Inc. Class A Common Stock

Compania de Distribucion Integral Logista Holdings, S.A.

Open Lending Corporation

A.P. Moller - Maersk A/S

MarketAxess Holdings Inc.

Monster Beverage Corporation

MP Materials Corp.

Motorsport Games Inc.

Nektar Therapeutics

NewLake Capital Partners, Inc.

FiscalNote Holdings, Inc.

NerdWallet Inc. Class A Common Stock

Nu Skin Enterprises, Inc.